Bis-D-menthyl performate | 93939-82-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Bis-D-menthyl performate
• 英文别名: bis[(1S,2R,5S)-5-methyl-2-propan-2-ylcyclohexyl] carbonate
• CAS: 93939-82-3
• 化学式: C₂₁H₃₈O₃
• 分子量: 338.5
• InChiKey: QFEHNMKROHXPFO-GTYQWKCWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.5
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• NOVEL CHIRAL DIHYDROBENZOOXAPHOSPHOLE LIGANDS AND SYNTHESIS THEREOF
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20180155375A1

  公开（公告）日：2018-06-07

  This invention relates to novel phosphorous ligands useful for organic transformations. Methods of making and using the ligands in organic synthesis are described. The invention also relates to processes for preparing the novel ligands.

  这项发明涉及用于有机转化的新型磷配体。描述了在有机合成中制备和使用这些配体的方法。该发明还涉及制备这些新型配体的方法。
• Modulators of cystic fibrosis transmembrane conductance regulator
  申请人：Hadida-Ruah Sarah

  公开号：US20080161371A1

  公开（公告）日：2008-07-03

  The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.

  本发明涉及囊性纤维化跨膜传导调节器（“CFTR”）的调节剂，其组成物以及使用此类调节剂的方法。本发明还涉及使用这种调节剂治疗CFTR介导疾病的方法。
• Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150126566A1

  公开（公告）日：2015-05-07

  The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.

  本发明涉及囊性纤维化跨膜传导调节因子（“CFTR”）的调节剂，其组合物和使用这些调节剂的方法。本发明还涉及使用这些调节剂治疗CFTR介导疾病的方法。
• MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20140121381A1

  公开（公告）日：2014-05-01

  The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.

  本发明涉及囊性纤维化跨膜传导调节因子（“CFTR”）的调节剂，以及其组成物和使用这些调节剂治疗CFTR介导的疾病的方法。
• Chiral dihydrobenzooxaphosphole ligands and synthesis thereof
  申请人：Boehringer Ingelheim International GmbH

  公开号：US10221203B2

  公开（公告）日：2019-03-05

  This invention relates to novel phosphorous ligands useful for organic transformations. Methods of making and using the ligands in organic synthesis are described. The invention also relates to processes for preparing the novel ligands.

  本发明涉及可用于有机转化的新型磷配体。本发明描述了在有机合成中制造和使用配体的方法。本发明还涉及制备新型配体的工艺。